Your browser doesn't support javascript.
loading
Autologous bioscaffolds based on different concentrations of platelet rich plasma and synovial fluid as a vehicle for mesenchymal stem cells.
Garate, Ane; Sánchez, Pello; Delgado, Diego; Bilbao, Ane Miren; Muiños-López, Emma; Granero-Moltó, Froilán; Orive, Gorka; Prosper, Felipe; Pedraz, José Luis; Sánchez, Mikel.
Affiliation
  • Garate A; Advanced Biological Therapy Unit- UTBA, Hospital Vithas San Jose, Vitoria-Gasteiz, Spain.
  • Sánchez P; Advanced Biological Therapy Unit- UTBA, Hospital Vithas San Jose, Vitoria-Gasteiz, Spain.
  • Delgado D; NanoBioCel group, Laboratory of Pharmaceutics, University of the Basque Country, School of Pharmacy, Vitoria-Gasteiz, Spain.
  • Bilbao AM; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain.
  • Muiños-López E; Advanced Biological Therapy Unit- UTBA, Hospital Vithas San Jose, Vitoria-Gasteiz, Spain.
  • Granero-Moltó F; Arthroscopic Surgery Unit-UCA, Hospital Vithas San Jose, Vitoria-Gasteiz, Spain.
  • Orive G; Cell Therapy and Experimental Orthopedics, University of Navarra Clinic, Pamplona, Spain.
  • Prosper F; Cell Therapy and Experimental Orthopedics, University of Navarra Clinic, Pamplona, Spain.
  • Pedraz JL; NanoBioCel group, Laboratory of Pharmaceutics, University of the Basque Country, School of Pharmacy, Vitoria-Gasteiz, Spain.
  • Sánchez M; Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain.
J Biomed Mater Res A ; 106(2): 377-385, 2018 02.
Article in En | MEDLINE | ID: mdl-28960933
In the field of tissue engineering, diverse types of bioscaffolds are being developed currently for osteochondral defect applications. In this work, a novel scaffold based on platelet rich plasma (PRP) and hyaluronic acid with mesenchymal stem cells (MSCs) has been evaluated to observe its effect on immobilized cells. The bioscaffolds were prepared by mixing different volumes of synovial fluid (SF) with PRP from patients obtaining three formulations at PRP-SF ratios of 3:1, 1:1 and 1:3 (v/v). The live/dead staining revealed that although the cell number of each type of bioscaffold was different, these this constructs provide cells with a suitable environment for their viability and proliferation. Moreover, immobilized MSCs showed their ability to secrete fibrinolytic enzymes, which vary depending on the fibrin amount of the scaffold. Immunohistochemical analysis revealed the positive staining for collagen type II in all cases, proving the biologic action of SF derived MSCs together with the suitable characteristics of the bioscaffold for chondrogenic differentiation. Considering all these aspects, this study demonstrates that these cells-based constructs represent an attractive method for cell immobilization, achieving completely autologous and biocompatible scaffolds. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 377-385, 2018.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Synovial Fluid / Platelet-Rich Plasma / Tissue Scaffolds / Mesenchymal Stem Cells Limits: Humans Language: En Journal: J Biomed Mater Res A Journal subject: ENGENHARIA BIOMEDICA Year: 2018 Document type: Article Affiliation country: Spain Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Synovial Fluid / Platelet-Rich Plasma / Tissue Scaffolds / Mesenchymal Stem Cells Limits: Humans Language: En Journal: J Biomed Mater Res A Journal subject: ENGENHARIA BIOMEDICA Year: 2018 Document type: Article Affiliation country: Spain Country of publication: United States